Renaissance Technologies - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 124 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$482
+217.1%
114,100
+49.3%
0.00%
Q4 2022$152
-99.9%
76,400
-46.2%
0.00%
Q3 2022$287,000
-47.6%
141,900
-17.7%
0.00%
-100.0%
Q2 2022$548,000
+91.6%
172,400
+151.3%
0.00%
Q1 2022$286,000
-90.5%
68,600
-84.7%
0.00%
-100.0%
Q1 2021$3,019,000
+282.6%
448,660
+160.0%
0.00%
+300.0%
Q4 2020$789,000
+53.5%
172,549
+140.7%
0.00%
Q2 2019$514,000
-90.6%
71,700
-81.5%
0.00%
-100.0%
Q1 2019$5,489,000
-57.5%
387,400
-59.4%
0.01%
-64.3%
Q4 2018$12,904,000
+52.7%
953,700
+150.5%
0.01%
+55.6%
Q3 2018$8,448,000380,7000.01%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders